🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: oxycodone prolonged release tablet

Found 0 matching trials

The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

It is well recognized that a multimodal analgesia program targeting multipl...

Status

Completed

Location

Rothman Institute

Start Date

2017-12-21

Trial ID

NCT04003350

Treatments Being Tested

Oxycodone Tramadol Tylenol Meloxicam Gabapentin Metaxalone Esomeprazole 20mg

Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty

The aim of this study is to assess the effectiveness of Sublingual Sufentan...

Status

Completed

Location

Chu Tivoli

Start Date

2017-09-01

Trial ID

NCT04448457

Treatments Being Tested

Sufentanil Sublingual Tablet Oxycodone oral tablet and oxycodone extended-release oral tablet

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

PHASE3

The primary objectives are * to demonstrate that the treatment with OXN PR...

Status

Completed

Location

Multiple Locations

Start Date

2009-05

Trial ID

NCT00902837

Treatments Being Tested

Oxycodone naloxone prolonged release tablets (OXN)oxycodone prolonged release tablet oxycodone naloxone tablet

A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy

PHASE2

To show superior analgesic efficacy of OXN PR in addition to a patient's cu...

Status

Completed

Location

Dr Oliver Emrich

Start Date

2009-07

Trial ID

NCT00944697

Treatments Being Tested

Oxycodone Naloxone Placebo tablets

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

PHASE3

The primary objective for the 12-week Titration-/Maintenance Period is: To...

Status

Completed

Location

Paracelsus Elena Klinik

Start Date

2010-04

Trial ID

NCT01112644

Treatments Being Tested

Oxycodone naloxone prolonged release tablets (OXN PR)Placebo (PLA)

A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

PHASE3

The purpose of this study is to evaluate the safety profile of tapentadol (...

Status

Completed

Location

Multiple Locations

Start Date

2006-11

Trial ID

NCT00361504

Treatments Being Tested

Oxycodone CR Tapentadol (CG5503) ER

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

PHASE4

Constipation is common in pregnant women. Surgery, anaesthesia and opioid a...

Status

Unknown

Location

Kuopio University Hospital

Start Date

2012-10

Trial ID

NCT02571881

Treatments Being Tested

Caesarean section Oxycodone oxycodone-naloxone

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

PHASE4

The purpose of this study is to compare oxycodone/naloxone combination tabl...

Status

Completed

Location

Multiple Locations

Start Date

2009-02

Trial ID

NCT00784810

Treatments Being Tested

Oxycodone/Naloxone Codeine/Paracetamol

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

PHASE3

The primary objective was to demonstrate the superiority of OXN over placeb...

Status

Completed

Location

Multiple Locations

Start Date

2005-01

Trial ID

NCT01971632

Treatments Being Tested

Oxycodone & naloxone combination, prolonged release placebo oxycodone / naloxone

OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty

PHASE4

The purpose of this study is to demonstrate that treatment with OXN PR tabl...

Status

Completed

Location

Central hospital of Pori

Start Date

2010-03

Trial ID

NCT01083485

Treatments Being Tested

Oxycodone/Naloxone PR 20/10mg or 10/5mg tablets Oxycodone

Previous Next